Assembly Biosciences, Inc.
General ticker "ASMB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $342.0M (TTM average)
Assembly Biosciences, Inc. follows the US Stock Market performance with the rate: 22.9%.
Estimated limits based on current volatility of 2.8%: low 25.67$, high 27.17$
Factors to consider:
- Total employees count: 73 (0.0%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: No approved products, R&D failure, Capital raising, Regulatory and compliance, Manufacturing risks
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [19.40$, 51.43$]
- 2026-12-31 to 2027-12-31 estimated range: [11.18$, 32.13$]
Financial Metrics affecting the ASMB estimates:
- Negative: with PPE of -45.4 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: -3.72 < Return on assets ratio (scaled to [-100,100]) of -2.32
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 80.26 > 64.23
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term ASMB quotes
Long-term ASMB plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7.16MM | $28.52MM | $72.30MM |
| Operating Expenses | $71.81MM | $73.94MM | $84.42MM |
| Operating Income | $-64.65MM | $-45.42MM | $-12.12MM |
| Non-Operating Income | $3.45MM | $5.57MM | $6.00MM |
| R&D Expense | $48.90MM | $55.93MM | $64.81MM |
| Income(Loss) | $-61.20MM | $-39.85MM | $-6.12MM |
| Taxes | $0.03MM | $0.33MM | $0.00MM |
| Net Income(Loss)* | $-61.23MM | $-40.18MM | $-6.12MM |
| Stockholders Equity | $41.10MM | $33.36MM | $206.75MM |
| Inventory | $3.20MM | $0.00MM | $0.00MM |
| Assets | $136.82MM | $119.17MM | $257.59MM |
| Operating Cash Flow | $22.74MM | $-51.12MM | $-41.09MM |
| Capital expenditure | $0.26MM | $0.03MM | $0.07MM |
| Investing Cash Flow | $-69.14MM | $40.17MM | $-113.47MM |
| Financing Cash Flow | $13.82MM | $29.45MM | $174.67MM |
| Earnings Per Share** | $-13.38 | $-6.69 | $-0.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.